WV HB3123

Requires FDA-certified mammography facilities to notify patients in writing when screening reveals heterogeneously or extremely dense breast tissue, as classified by the American College of Radiology's Breast Imaging Reporting and Data System

Mandates specific notification language explaining that dense breast tissue is common but can make cancer detection more difficult and may increase breast cancer risk

Requires notification to inform patients about potential benefits of additional imaging tests such as screening breast ultrasound or breast MRI

Requires breast density category information to be included in mammography reports sent to the patient's referring or named healthcare provider

Allows facilities to provide supplemental educational materials about breast density, including American College of Radiology brochures or information from DenseBreast-info.org